Oxcarbazepine Monotherapy
Abstract
The efficacy of oxcarbazepine monotherapy in 60 children and adolescents (aged 6 months to 17.8 years; mean age 8.2 yrs) with partial onset epilepsy was evaluated by retrospective chart review in a study at St Christopher’s Hospital for Children, Philadelphia, PA.
DOI: https://doi.org/10.15844/pedneurbriefs-20-10-9 | Journal eISSN: 2166-6482
Language: English
Page range: 79 - 80
Published on: Oct 1, 2006
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.